From clinical description, to in vitro and animal studies, and backward to patients: Oxidative stress and mitochondrial dysfunction in Fanconi anemia

Free Radical Biology and Medicine

Volumn 58, Issue , 2013, Pages 118-125

  Pagano, Giovanni ^a   Aiello Talamanca, Annarita ^a   Castello, Giuseppe ^a   D'Ischia, Marco ^b   Pallardó, Federico V ^c   Petrović, Sandra ^d   Porto, Beatriz ^e   Tiano, Luca ^f   Zatterale, Adriana ^g  

^a ITN Cancer Research Center   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c UNIVERSITY OF VALENCIA   (Spain)

^d UNIVERSITY OF BELGRADE   (Serbia)

^e UNIVERSITY OF PORTO   (Portugal)

^f UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^g Elena d'Aosta Hospital   (Italy)

Author keywords

Chemoprevention; Fanconi anemia; Free radicals; Mitochondrial dysfunction; Mitochondrial nutrients

Indexed keywords

FANCONI ANEMIA PROTEIN; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE FERRIHEMOPROTEIN REDUCTASE;

ANIMAL EXPERIMENT; ARTICLE; BODY FLUID; BONE MARROW DEPRESSION; CHEMOPROPHYLAXIS; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DNA DAMAGE; FANCONI ANEMIA; IN VITRO STUDY; IN VIVO STUDY; KNOCKOUT MOUSE; LEUKEMIA; MITOCHONDRIAL MEMBRANE POTENTIAL; MOUSE; NITROSATIVE STRESS; NONHUMAN; OXIDATIVE STRESS; PHENOTYPE; PRIORITY JOURNAL;

ANIMALIA;

EID: 84874943800     PISSN: 08915849     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2013.01.015     Document Type: Review

References (98)

1. G. Fanconi Familiäre infantile perniziosartige Anämie (perniziöses Blutbild und Konstitution) Jb. Kinderheilkd 117 1927 257 281
2. H.L. Bonkovsky Iron and the liver Am. J. Med. Sci. 301 1991 32 43
3. G. Papanikolaou, and K. Pantopoulos Iron metabolism and toxicity Toxicol. Appl. Pharmacol. 202 2005 199 211
4. K. Broedbaek, H.E. Poulsen, A. Weimann, G.D. Kom, E. Schwedhelm, P. Nielsen, and R.H. Böger Urinary excretion of biomarkers of oxidatively damaged DNA and RNA in hereditary hemochromatosis Free Radic. Biol. Med. 47 2009 1230 1233
5. C. Masserot-Lureau, N. Adoui, F. Degos, C. de Bazelaire, J. Soulier, S. Chevret, G. Socié, and T. Leblanc Incidence of liver abnormalities in Fanconi anemia patients Am. J. Hematol. 87 2012 547 549
6. Y.H. Chang, C.F. Shaw, K.H. Wu, K.H. Hsieh, Y.N. Su, and P.J. Lu Treatment with deferiprone for iron overload alleviates bone marrow failure in a Fanconi anemia patient Hemoglobin 33 2009 346 351
7. B. Tunç, B. Tavil, N. Karakurt, N. Yarali, F.M. Azik, A. Kara, V. Culha, and S. Ozkasap Deferasirox therapy in children with Fanconi aplastic anemia J. Pediatr. Hematol. Oncol. 34 2012 247 251
8. J.H. Jones Foetal haemoglobin in Fanconi type anaemia Nature 192 1961 982
9. I. Syllm-Rapoport, D. Gmyrek, H.J. Altenbrunn, D. Scheuch, and G. Jacobasch Studies on hemolysis in Fanconi's anemia: increase of ATP-ase as a possible cause for decreased ATP values Dtsch. Med. Wochenschr. 90 1965 290 296
10. A.D. Auerbach Fanconi anemia and its diagnosis Mutat. Res. 668 2009 4 10
11. A.M. Green, and G.M. Kupfer Fanconi anemia Hematol. Oncol. Clin. North Am. 23 2009 193 214
12. G.P. Crossan, and K.J. Patel The Fanconi anaemia pathway orchestrates incisions at sites of crosslinked DNA J. Pathol. 226 2012 326 337
13. A.D. D'Andrea Susceptibility pathways in Fanconi's anemia and breast cancer N. Engl. J. Med. 362 2010 1909 1919
14. G. Pagano, A.A. Talamanca, G. Castello, F.V. Pallardó, A. Zatterale, and P. Degan Oxidative stress in Fanconi anaemia: from cells and molecules toward prospects in clinical management Biol. Chem. 393 2012 11 21
15. I. Nordenson Effect of superoxide dismutase and catalase on spontaneously occurring chromosome breaks in patients with Fanconi's anemia Hereditas 86 1977 147 150
16. H. Joenje, F. Arwert, A.W. Eriksson, H. de Koning, and A.B. Oostra Oxygen-dependence of chromosomal aberrations in Fanconi's anaemia Nature 290 1981 142 143
17. D. Schindler, and H. Hoehn Fanconi anemia mutation causes cellular susceptibility to ambient oxygen Am. J. Hum. Genet. 43 1988 429 435
18. T. Takeuchi, and K. Morimoto Increased formation of 8- hydroxydeoxyguanosine, an oxidative DNA damage, in lymphoblasts from Fanconi's anemia patients due to possible catalase deficiency Carcinogenesis 14 1993 1115 1120
19. A.A. Clarke, N.J. Philpott, E.C. Gordon-Smith, and T.R. Rutherford The sensitivity of Fanconi anaemia group C cells to apoptosis induced by mitomycin C is due to oxygen radical generation, not DNA crosslinking Br. J. Haematol. 96 1997 240 247
20. F. Ponte, R. Sousa, A.P. Fernandes, C. Gonçalves, J. Barbot, F. Carvalho, and B. Porto Improvement of genetic stability in lymphocytes from Fanconi anemia patients through the combined effect of α-lipoic acid and N-acetylcysteine Orphanet J. Rare Dis. 7 2012 28
21. W. Du, R. Rani, J. Sipple, J. Schick, K.C. Myers, P. Mehta, P.R. Andreassen, S.M. Davies, and Q. Pang The FA pathway counteracts oxidative stress through selective protection of antioxidant defense gene promoters Blood 119 2012 4142 4151
22. B.R. Berquist, and D.M. Wilson 3rd Pathways for repairing and tolerating the spectrum of oxidative DNA lesions Cancer Lett. 327 2012 61 72
23. L.G. Korkina, E.V. Samochatova, A.A. Maschan, T.B. Suslova, Z.P. Cheremisina, and I.B. Afanas'ev Release of active oxygen radicals by leukocytes of Fanconi anemia patients J. Leukocyte Biol. 52 1992 357 362
24. J.C. Schultz, and N.T. Shahidi Detection of tumor necrosis factor-alpha in bone marrow plasma and peripheral blood plasma from patients with aplastic anemia Am. J. Hematol 45 1994 32 38
25. I. Emerit, A. Levy, G. Pagano, L. Pinto, R. Calzone, and A. Zatterale Transferable clastogenic activity in plasma from patients with Fanconi anemia Hum. Genet. 96 1995 14 20
26. P. Degan, S. Bonassi, M. De Caterina, L.G. Korkina, L. Pinto, F. Scopacasa, A. Zatterale, R. Calzone, and G. Pagano In vivo accumulation of 8-hydroxy-2′-deoxyguanosine in DNA correlates with release of reactive oxygen species in Fanconi's anaemia families Carcinogenesis 16 1995 735 741
27. G. Pagano, P. Degan, M. d'Ischia, F.J. Kelly, F.V. Pallardo, A. Zatterale, S.S. Anak, E.E. Akisik, G. Beneduce, R. Calzone, E. De Nicola, C. Dunster, A. Lloret, P. Manini, B. Nobili, A. Saviano, E. Vuttariello, and M. Warnau Gender- and age-related distinctions for the in vivo prooxidant state in Fanconi anaemia patients Carcinogenesis 25 2004 1899 1909
28. S. Petrović, A. Leskovac, J. Kotur-Stevuljević, J. Joksić, M. Guc-Scekić, D. Vujić, and G. Joksić Gender-related differences in the oxidant state of cells in Fanconi anemia heterozygotes Biol. Chem. 392 2011 625 632
29. K. Yoshimitsu, Y. Kobayashi, and T. Usui Decreased superoxide dismutase activity of erythrocytes and leukocytes in Fanconi's anemia Acta Haematol. 72 1984 208 210
30. S. Hadjur, K. Ung, L. Wadsworth, J. Dimmick, E. Rajcan-Separovic, R.W. Scott, M. Buchwald, and F.R. Jirik Defective hematopoiesis and hepatic steatosis in mice with combined deficiencies of the genes encoding Fancc and Cu/Zn superoxide dismutase Blood 98 2001 1003 1011
31. D.P. Sejas, R. Rani, Y. Qiu, X. Zhang, S.R. Fagerlie, H. Nakano, D.A. Williams, and Q. Pang Inflammatory reactive oxygen species-mediated hemopoietic suppression in Fancc-deficient mice J. Immunol. 178 2007 5277 5287
32. R. Rani, J. Li, and Q. Pang Differential p53 engagement in response to oxidative and oncogenic stresses in Fanconi anemia mice Cancer Res 68 2008 9693 9702
33. Q.S. Zhang, L. Eaton, E.R. Snyder, S. Houghtaling, J.B. Mitchell, M. Finegold, C. Van Waes, and M. Grompe Tempol protects against oxidative damage and delays epithelial tumor onset in Fanconi anemia mice Cancer Res. 68 2008 1601 1608
34. -/- mice have hematopoietic defects that can be partially corrected by resveratrol Blood 116 2010 5140 5148
35. J. Li, J. Sipple, S. Maynard, P.A. Mehta, S.R. Rose, S.M. Davies, and Q. Pang Fanconi anemia links reactive oxygen species to insulin resistance and obesity Antioxid. Redox Signaling 17 2012 1083 1098
36. S.S. Mukhopadhyay, K.S. Leung, M.J. Hicks, P.J. Hastings, H. Youssoufian, and S.E. Plon Defective mitochondrial peroxiredoxin-3 results in sensitivity to oxidative stress in Fanconi anemia J. Cell Biol. 175 2006 225 235
37. Kumari, U.; Jun, W. Y.; Bay, B. H.; Lyakhovich, A. Evidence of mitochondrial dysfunction and impaired ROS detoxifying machinery in Fanconi anemia cells. Oncogene, 10.1016/10.1038/onc.2012.583; in press
38. M. Bogliolo, S. Borghini, A. Abbondandolo, and P. Degan Alternative metabolic pathways for energy supply and resistance to apoptosis in Fanconi anaemia Mutagenesis 17 2002 25 30
39. R. Zanier, D. Briot, J.A. Dugas du Villard, A. Sarasin, and F. Rosselli Fanconi anemia C gene product regulates expression of genes involved in differentiation and inflammation Oncogene 23 2004 5004 5013
40. S. Rousset, S. Nocentini, D. Rouillard, C. Baroche, and E. Moustacchi Mitochondrial alterations in Fanconi anemia fibroblasts following ultraviolet A or psoralen photoactivation Photochem. Photobiol. 75 2002 159 166
41. S.J. Park, S.L. Ciccone, B.D. Beck, B. Hwang, B. Freie, D.W. Clapp, and S.H. Lee Oxidative stress/damage induces multimerization and interaction of Fanconi anemia proteins J. Biol. Chem. 279 2004 30053 30059
42. F.A. Kruyt, T. Hoshino, J.M. Liu, P. Joseph, A.K. Jaiswal, and H. Youssoufian Abnormal microsomal detoxification implicated in Fanconi anemia group C by interaction of the FAC protein with NADPH cytochrome P450 reductase Blood 92 1998 3050 3056
43. M. Futaki, T. Igarashi, S. Watanabe, S. Kajigaya, A. Tatsuguchi, J. Wang, and J.M. Liu The FANCG Fanconi anemia protein interacts with CYP2E1: possible role in protection against oxidative DNA damage Carcinogenesis 23 2002 67 72
44. R.C. Cumming, J. Lightfoot, K. Beard, H. Youssoufian, P.J. O'Brien, and M. Buchwald Fanconi anemia group C protein prevents apoptosis in hematopoietic cells through redox regulation of GSTP1 Nat. Med 7 2001 814 820
45. P. Castillo, M. Bogliolo, and J. Surralles Coordinated action of the Fanconi anemia and ataxia telangiectasia pathways in response to oxidative damage DNA Repair 10 2011 518 525
46. J. Li, W. Du, S. Maynard, P.R. Andreassen, and Q. Pang Oxidative stress-specific interaction between FANCD2 and FOXO3a Blood 115 2010 1545 1548
47. S.B. Cantor, and P.R. Andreassen Assessing the link between BACH1 and BRCA1 in the FA pathway Cell Cycle 5 2006 164 167
48. O. Levran, C. Attwooll, R.T. Henry, K.L. Milton, K. Neveling, P. Rio, S.D. Batish, R. Kalb, E. Velleuer, S. Barral, J. Ott, J. Petrini, D. Schindler, H. Hanenberg, and A.D. Auerbach The BRCA1-interacting helicase BRIP1 is deficient in Fanconi anemia Nat. Genet. 37 2005 931 933
49. B. Vurusaner, G. Poli, and H. Basaga Tumor suppressor genes and ROS: complex networks of interactions Free Radic. Biol. Med. 52 2012 7 18
50. S. Dhakshinamoorthy, A.K. Jain, D.A. Bloom, and A.K. Jaiswal Bach1 competes with Nrf2 leading to negative regulation of the antioxidant response element (ARE)-mediated NAD(P)H:quinone oxidoreductase 1 gene expression and induction in response to antioxidants J. Biol. Chem 280 2005 16891 16900
51. R.J. Monnat Jr. Human RECQ helicases: roles in DNA metabolism, mutagenesis and cancer biology Semin. Cancer Biol. 20 2010 329 339
52. T. Kitamuro, K. Takahashi, K. Ogawa, R. Udono-Fujimori, K. Takeda, K. Furuyama, M. Nakayama, J. Sun, H. Fujita, W. Hida, T. Hattori, K. Shirato, K. Igarashi, and S. Shibahara Bach1 functions as a hypoxia-inducible repressor for the heme oxygenase-1 gene in human cells J. Biol. Chem. 278 2003 9125 9133
53. S. Okada, A. Muto, E. Ogawa, A. Nakanome, Y. Katoh, S. Ikawa, S. Aiba, K. Igarashi, and R. Okuyama Bach1-dependent and -independent regulation of heme oxygenase-1 in keratinocytes J. Biol. Chem. 285 2010 23581 23589
54. A.N. Suhasini, J.A. Sommers, A.C. Mason, O.N. Voloshin, R.D. Camerini-Otero, M.S. Wold, and R.M. Brosh Jr. FANCJ helicase uniquely senses oxidative base damage in either strand of duplex DNA and is stimulated by replication protein A to unwind the damaged DNA substrate in a strand-specific manner J. Biol. Chem. 284 2009 18458 18470
55. Y. Kamenisch, and M. Berneburg Progeroid syndromes and UV-induced oxidative DNA damage Invest. Dermatol. Symp. Proc 14 2009 8 14
56. M.F. Lavin, N. Gueven, S. Bottle, and R.A. Gatti Current and potential therapeutic strategies for the treatment of ataxia-telangiectasia Br. Med. Bull. 81-82 2007 129 147
57. D. Marmolino Friedreich's ataxia: past, present and future 67 2011 311 330 Brain Res. Rev. 67 2011 311 330
58. A. Lloret, R. Calzone, C. Dunster, P. Manini, M. d'Ischia, P. Degan, F.J. Kelly, F.V. Pallardó, A. Zatterale, and G. Pagano Different patterns of in vivo pro-oxidant states in a set of cancer- or aging-related genetic diseases Free Radic. Biol. Med. 44 2008 495 503
59. F.V. Pallardó, A. Lloret, M. Lebel, M. d'Ischia, V.C. Cogger, D.G. Le Couteur, M.N. Gadaleta, G. Castello, and G. Pagano Mitochondrial dysfunction in some oxidative stress-related genetic diseases: ataxia-telangiectasia, Down syndrome, Fanconi anaemia and Werner syndrome Biogerontology 11 2010 401 419
60. M. Perluigi, and D.A. Butterfield Oxidative stress and Down syndrome: a route toward Alzheimer-like dementia Curr. Gerontol. Geriatr. Res 2012 2012 724904
61. G. Pagano, and G. Castello Oxidative stress and mitochondrial dysfunction in Down syndrome Adv. Exp. Med. Biol. 724 2012 291 299
62. K. Ryo, H. Yamada, Y. Nakagawa, Y. Tai, K. Obara, H. Inoue, K. Mishima, and I. Saito Possible involvement of oxidative stress in salivary gland of patients with Sjogren's syndrome Pathobiology 73 2006 252 260
63. G. Pagano, G. Castello, and F.V. Pallardó Sjøgren's syndrome-associated oxidative stress and mitochondrial dysfunction: prospects for chemoprevention trials Free Radic. Res. 47 2012 71 73
64. J. Lee, S. Giordano, and J. Zhang Autophagy, mitochondria and oxidative stress: cross-talk and redox signalling Biochem. J. 441 2012 523 540
65. A.S. Watson, M. Mortensen, and A.K. Simon Autophagy in the pathogenesis of myelodysplastic syndrome and acute myeloid leukemia Cell Cycle 10 2011 1719 1725
66. L. Pácal, J. Varvarovská, Z. Rušavý, S. Lacigová, R. Stetina, J. Racek, R. Pomahacová, V. Tanhäuserová, and K. Kanková Parameters of oxidative stress, DNA damage and DNA repair in type 1 and type 2 diabetes mellitus Arch. Physiol. Biochem. 117 2011 222 230
67. L. Novellino, A. Napolitano, and G. Prota 5,6-Dihydroxyindoles in the Fenton reaction: a model study of the role of melanin precursors in oxidative stress and hyperpigmentary processes Chem. Res. Toxicol 12 1999 985 992
68. P.G. Penketh, W.F. Hodnick, M.F. Belcourt, K. Shyam, D.H. Sherman, and A.C. Sartorelli Inhibition of DNA crosslinking by mitomycin C by peroxidase-mediated oxidation of mitomycin C hydroquinone J. Biol. Chem. 276 2001 34445 34452
69. C.A. Pritsos, and A.C. Sartorelli Generation of reactive oxygen radicals through bioactivation of mitomycin antibiotics Cancer Res. 46 1986 3528 3532
70. A.J. Lambert, and M.D. Brand Reactive oxygen species production by mitochondria Methods Mol. Biol. 554 2009 165 181
71. Malik, A. N.; Czajka, A. Is mitochondrial DNA content a potential biomarker of mitochondrial dysfunction? Mitochondrion, 10.1016/j.mito.2012.10. 011; in press.
72. L.J. Wong, C.L. Perng, C.H. Hsu, R.K. Bai, S. Schelley, G.D. Vladutiu, H. Vogel, and G.M. Enns Compensatory amplification of mtDNA in a patient with a novel deletion/duplication and high mutant load J. Med. Genet. 40 2003 e125
73. A. Spinazzola Mitochondrial DNA mutations and depletion in pediatric medicine Semin. Fetal Neonatal Med 16 2011 190 196
74. Y.A. Valentin-Vega, K.H. MacLean, J. Tait-Mulder, S. Milasta, M. Steeves, F.C. Dorsey, J.L. Cleveland, D.R. Green, and M.B. Kastan Mitochondrial dysfunction in ataxia telangiectasia Blood 119 2012 1490 1500
75. D. Cotan, M.D. Cordero, J. Garrido-Maraver, M. Oropesa-Avila, A. Rodríguez-Hernandez, L.G. Izquierdo, M. De la Mata, M. De Miguel, J.B. Lorite, E.R. Infante, S. Jackson, P. Navas, and J.A. Sanchez-Alcazar Secondary coenzyme Q10 deficiency triggers mitochondria degradation by mitophagy in MELAS fibroblasts FASEB J 25 2011 2669 2687
76. R. Mastrocola, F. Restivo, I. Vercellinatto, O. Danni, E. Brignardello, M. Aragno, and G. Boccuzzi Oxidative and nitrosative stress in brain mitochondria of diabetic rats J. Endocrinol. 187 2005 37 44
77. A.J. Gow, C.R. Farkouh, D.A. Munson, M.A. Posencheg, and H. Ischiropoulos Biological significance of nitric oxide-mediated protein modifications Am. J. Physiol. Lung Cell Mol. Physiol 287 2004 L262 L268
78. S. Hadjur, and F.R. Jirik Increased sensitivity of Fancc-deficient hematopoietic cells to nitric oxide and evidence that this species mediates growth inhibition by cytokines Blood 101 2003 3877 3884
79. S. Sabuncuoǧlu, Y. Öztaş, D.U. Çetinkaya, N. Özgüneş, and N. Özgüneş Oxidative protein damage with carbonyl levels and nitrotyrosine expression after chemotherapy in bone marrow transplantation patients Pharmacology 89 2012 283 286
80. M.A. Tarnopolsky The mitochondrial cocktail: rationale for combined nutraceutical therapy in mitochondrial cytopathies Adv. Drug Delivery Rev 60 2008 1561 1567
81. L. Tiano, P. Carnevali, L. Padella, L. Santoro, F. Principi, F. Brugè, F. Carle, R. Gesuita, O. Gabrielli, and G.P. Littarru Effect of coenzyme Q10 in mitigating oxidative DNA damage in Down syndrome patients, a double blind randomized controlled trial Neurobiol. Aging 32 2011 2103 2105
82. A.E. Wagner, I.M. Ernst, M. Birringer, O. Sancak, L. Barella, and G. Rimbach A combination of lipoic acid plus coenzyme Q10 induces PGC1α, a master switch of energy metabolism, improves stress response, and increases cellular glutathione levels in cultured C2C12 skeletal muscle cells Oxid. Med. Cell Longevity 2012 2012 835970
83. S. Golbidi, and I. Laher Antioxidant therapy in human endocrine disorders Med. Sci. Monit. 16 2010 RA9 RA24
84. A. Hassani, R. Horvath, and P.F. Chinnery Mitochondrial myopathies: developments in treatment Curr. Opin. Neurol. 23 2010 459 465
85. Z.X. Poh, and K.P. Goh A current update on the use of alpha lipoic acid in the management of type 2 diabetes mellitus Endocr. Metab. Immune Disord. Drug Targets 9 2009 392 398
86. 10 effect on clinical improvement PLoS One 7 2012 e35677
87. Y.L. Dai, T.H. Luk, K.H. Yiu, M. Wang, P.M. Yip, S.W. Lee, S.W. Li, S. Tam, B. Fong, C.P. Lau, C.W. Siu, and H.F. Tse Reversal of mitochondrial dysfunction by coenzyme Q10 supplement improves endothelial function in patients with ischaemic left ventricular systolic dysfunction: a randomized controlled trial Atherosclerosis 216 2011 395 401
88. A. Goraça, H. Huk-Kolega, A. Piechota, P. Kleniewska, E. Ciejka, and B. Skibska Lipoic acid - biological activity and therapeutic potential Pharmacol. Rep. 63 2011 849 858
89. L. Packer, K. Kraemer, and G. Rimbach Molecular aspects of lipoic acid in the prevention of diabetes complications Nutrition 17 2001 888 895
90. D. Orsucci, M. Mancuso, E.C. Ienco, A. LoGerfo, and G. Siciliano Targeting mitochondrial dysfunction and neurodegeneration by means of coenzyme Q10 and its analogues Curr. Med. Chem. 18 2011 4053 4064
91. T. Blatt, and G.P. Littarru Biochemical rationale and experimental data on the antiaging properties of CoQ(10) at skin level Biofactors 37 2011 381 385
92. M.D. Cordero, E. Díaz-Parrado, A.M. Carrión, S. Alfonsi, J.A. Sánchez-Alcázar, P. Bullon, M. Battino, and M. de Miguel Is inflammation a mitochondrial dysfunction-dependent event in fibromyalgia? Antioxid. Redox Signaling 18 2013 800 807
93. M.D. Cordero, D. Cotán, Y. del-Pozo-Martín, A.M. Carrión, M. de Miguel, P. Bullón, and J.A. Sánchez-Alcazar Oral coenzyme Q10 supplementation improves clinical symptoms and recovers pathologic alterations in blood mononuclear cells in a fibromyalgia patient Nutrition 28 2012 1200 1203
94. J. Viña, M.C. Gomez-Cabrera, C. Borrás, T. Froio, F. Sanchis-Gomar, V.E. Martinez-Bello, and F.V. Pallardó Mitochondrial biogenesis in exercise and in ageing Adv. Drug Delivery Rev 61 2009 1369 1374
95. C. Indiveri, V. Iacobazzi, A. Tonazzi, N. Giangregorio, V. Infantino, P. Convertini, L. Console, and F. Palmieri The mitochondrial carnitine/ acylcarnitine carrier: function, structure and physiopathology Mol. Aspects Med. 32 2011 223 233
96. R. Ringseis, J. Keller, and K. Eder Role of carnitine in the regulation of glucose homeostasis and insulin sensitivity: evidence from in vivo and in vitro studies with carnitine supplementation and carnitine deficiency Eur. J. Nutr 51 2012 1 18
97. P.I. Moreira, P.L. Harris, X. Zhu, M.S. Santos, C.R. Oliveira, M.A. Smith, and G. Perry Lipoic acid and N-acetyl cysteine decrease mitochondrial-related oxidative stress in Alzheimer disease patient fibroblasts J. Alzheimers Dis. 12 2007 195 206
98. R. González, G. Ferrín, A.B. Hidalgo, I. Ranchal, P. López-Cillero, M. Santos-Gónzalez, G. López-Lluch, J. Briceño, M.A. Gómez, A. Poyato, J.M. Villalba, P. Navas, M. de la Mata, and J. Muntané N-acetylcysteine, coenzyme Q10 and superoxide dismutase mimetic prevent mitochondrial cell dysfunction and cell death induced by d-galactosamine in primary culture of human hepatocytes Chem. Biol. Interact. 181 2009 95 106